Global Circulating Biomarker for Liquid Biopsy Market Research Report 2023

The global Circulating Biomarker for Liquid Biopsy market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Circulating Biomarker for Liquid Biopsy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Circulating Biomarker for Liquid Biopsy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Circulating Biomarker for Liquid Biopsy in Early Cancer Screening is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Circulating Biomarker for Liquid Biopsy include Abbott Laboratories, Becton, Dickinson and Company, GE Healthcare, Epigenomics AG, Agilent Technologies, Biocept, Affymetrix and Fluxion Biosciences, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Circulating Biomarker for Liquid Biopsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circulating Biomarker for Liquid Biopsy.

The Circulating Biomarker for Liquid Biopsy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Circulating Biomarker for Liquid Biopsy market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Circulating Biomarker for Liquid Biopsy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Circulating Tumor Cells (CTCs)

1.2.3 Circulating Tumor DNA (ctDNA)

1.2.4 Cell-Free DNA (cfDNA)

1.2.5 Extracellular Vesicles (EVs)

1.2.6 Others

1.3 Market by Application

1.3.1 Global Circulating Biomarker for Liquid Biopsy Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Early Cancer Screening

1.3.3 Therapy Selection

1.3.4 Treatment Monitoring

1.3.5 Recurrence Monitoring Orthopedics

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Circulating Biomarker for Liquid Biopsy Market Perspective (2018-2029)

2.2 Circulating Biomarker for Liquid Biopsy Growth Trends by Region

2.2.1 Global Circulating Biomarker for Liquid Biopsy Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Circulating Biomarker for Liquid Biopsy Historic Market Size by Region (2018-2023)

2.2.3 Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Region (2024-2029)

2.3 Circulating Biomarker for Liquid Biopsy Market Dynamics

2.3.1 Circulating Biomarker for Liquid Biopsy Industry Trends

2.3.2 Circulating Biomarker for Liquid Biopsy Market Drivers

2.3.3 Circulating Biomarker for Liquid Biopsy Market Challenges

2.3.4 Circulating Biomarker for Liquid Biopsy Market Restraints

3.1 Global Top Circulating Biomarker for Liquid Biopsy Players by Revenue

3.1.1 Global Top Circulating Biomarker for Liquid Biopsy Players by Revenue (2018-2023)

3.1.2 Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Players (2018-2023)

3.2 Global Circulating Biomarker for Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Circulating Biomarker for Liquid Biopsy Revenue

3.4 Global Circulating Biomarker for Liquid Biopsy Market Concentration Ratio

3.4.1 Global Circulating Biomarker for Liquid Biopsy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Circulating Biomarker for Liquid Biopsy Revenue in 2022

3.5 Circulating Biomarker for Liquid Biopsy Key Players Head office and Area Served

3.6 Key Players Circulating Biomarker for Liquid Biopsy Product Solution and Service

3.7 Date of Enter into Circulating Biomarker for Liquid Biopsy Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Circulating Biomarker for Liquid Biopsy Historic Market Size by Type (2018-2023)

4.2 Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Type (2024-2029)

5.1 Global Circulating Biomarker for Liquid Biopsy Historic Market Size by Application (2018-2023)

5.2 Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Application (2024-2029)

6.1 North America Circulating Biomarker for Liquid Biopsy Market Size (2018-2029)

6.2 North America Circulating Biomarker for Liquid Biopsy Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Circulating Biomarker for Liquid Biopsy Market Size by Country (2018-2023)

6.4 North America Circulating Biomarker for Liquid Biopsy Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Circulating Biomarker for Liquid Biopsy Market Size (2018-2029)

7.2 Europe Circulating Biomarker for Liquid Biopsy Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2018-2023)

7.4 Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size (2018-2029)

8.2 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Region (2018-2023)

8.4 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Circulating Biomarker for Liquid Biopsy Market Size (2018-2029)

9.2 Latin America Circulating Biomarker for Liquid Biopsy Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country (2018-2023)

9.4 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size (2018-2029)

10.2 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Country (2018-2023)

10.4 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Detail

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Circulating Biomarker for Liquid Biopsy Introduction

11.1.4 Abbott Laboratories Revenue in Circulating Biomarker for Liquid Biopsy Business (2018-2023)

11.1.5 Abbott Laboratories Recent Development

11.2 Becton, Dickinson and Company

11.2.1 Becton, Dickinson and Company Company Detail

11.2.2 Becton, Dickinson and Company Business Overview

11.2.3 Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Introduction

11.2.4 Becton, Dickinson and Company Revenue in Circulating Biomarker for Liquid Biopsy Business (2018-2023)

11.2.5 Becton, Dickinson and Company Recent Development

11.3 GE Healthcare

11.3.1 GE Healthcare Company Detail

11.3.2 GE Healthcare Business Overview

11.3.3 GE Healthcare Circulating Biomarker for Liquid Biopsy Introduction

11.3.4 GE Healthcare Revenue in Circulating Biomarker for Liquid Biopsy Business (2018-2023)

11.3.5 GE Healthcare Recent Development

11.4 Epigenomics AG

11.4.1 Epigenomics AG Company Detail

11.4.2 Epigenomics AG Business Overview

11.4.3 Epigenomics AG Circulating Biomarker for Liquid Biopsy Introduction

11.4.4 Epigenomics AG Revenue in Circulating Biomarker for Liquid Biopsy Business (2018-2023)

11.4.5 Epigenomics AG Recent Development

11.5 Agilent Technologies

11.5.1 Agilent Technologies Company Detail

11.5.2 Agilent Technologies Business Overview

11.5.3 Agilent Technologies Circulating Biomarker for Liquid Biopsy Introduction

11.5.4 Agilent Technologies Revenue in Circulating Biomarker for Liquid Biopsy Business (2018-2023)

11.5.5 Agilent Technologies Recent Development

11.6 Biocept

11.6.1 Biocept Company Detail

11.6.2 Biocept Business Overview

11.6.3 Biocept Circulating Biomarker for Liquid Biopsy Introduction

11.6.4 Biocept Revenue in Circulating Biomarker for Liquid Biopsy Business (2018-2023)

11.6.5 Biocept Recent Development

11.7 Affymetrix

11.7.1 Affymetrix Company Detail

11.7.2 Affymetrix Business Overview

11.7.3 Affymetrix Circulating Biomarker for Liquid Biopsy Introduction

11.7.4 Affymetrix Revenue in Circulating Biomarker for Liquid Biopsy Business (2018-2023)

11.7.5 Affymetrix Recent Development

11.8 Fluxion Biosciences

11.8.1 Fluxion Biosciences Company Detail

11.8.2 Fluxion Biosciences Business Overview

11.8.3 Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Introduction

11.8.4 Fluxion Biosciences Revenue in Circulating Biomarker for Liquid Biopsy Business (2018-2023)

11.8.5 Fluxion Biosciences Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Circulating Tumor Cells (CTCs)

    Table 3. Key Players of Circulating Tumor DNA (ctDNA)

    Table 4. Key Players of Cell-Free DNA (cfDNA)

    Table 5. Key Players of Extracellular Vesicles (EVs)

    Table 6. Key Players of Others

    Table 7. Global Circulating Biomarker for Liquid Biopsy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Circulating Biomarker for Liquid Biopsy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global Circulating Biomarker for Liquid Biopsy Market Size by Region (2018-2023) & (US$ Million)

    Table 10. Global Circulating Biomarker for Liquid Biopsy Market Share by Region (2018-2023)

    Table 11. Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 12. Global Circulating Biomarker for Liquid Biopsy Market Share by Region (2024-2029)

    Table 13. Circulating Biomarker for Liquid Biopsy Market Trends

    Table 14. Circulating Biomarker for Liquid Biopsy Market Drivers

    Table 15. Circulating Biomarker for Liquid Biopsy Market Challenges

    Table 16. Circulating Biomarker for Liquid Biopsy Market Restraints

    Table 17. Global Circulating Biomarker for Liquid Biopsy Revenue by Players (2018-2023) & (US$ Million)

    Table 18. Global Circulating Biomarker for Liquid Biopsy Market Share by Players (2018-2023)

    Table 19. Global Top Circulating Biomarker for Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Biomarker for Liquid Biopsy as of 2022)

    Table 20. Ranking of Global Top Circulating Biomarker for Liquid Biopsy Companies by Revenue (US$ Million) in 2022

    Table 21. Global 5 Largest Players Market Share by Circulating Biomarker for Liquid Biopsy Revenue (CR5 and HHI) & (2018-2023)

    Table 22. Key Players Headquarters and Area Served

    Table 23. Key Players Circulating Biomarker for Liquid Biopsy Product Solution and Service

    Table 24. Date of Enter into Circulating Biomarker for Liquid Biopsy Market

    Table 25. Mergers & Acquisitions, Expansion Plans

    Table 26. Global Circulating Biomarker for Liquid Biopsy Market Size by Type (2018-2023) & (US$ Million)

    Table 27. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Type (2018-2023)

    Table 28. Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 29. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Type (2024-2029)

    Table 30. Global Circulating Biomarker for Liquid Biopsy Market Size by Application (2018-2023) & (US$ Million)

    Table 31. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Application (2018-2023)

    Table 32. Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 33. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Application (2024-2029)

    Table 34. North America Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. North America Circulating Biomarker for Liquid Biopsy Market Size by Country (2018-2023) & (US$ Million)

    Table 36. North America Circulating Biomarker for Liquid Biopsy Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Europe Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2018-2023) & (US$ Million)

    Table 39. Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2024-2029) & (US$ Million)

    Table 40. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Region (2018-2023) & (US$ Million)

    Table 42. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Region (2024-2029) & (US$ Million)

    Table 43. Latin America Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 47. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Country (2018-2023) & (US$ Million)

    Table 48. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Country (2024-2029) & (US$ Million)

    Table 49. Abbott Laboratories Company Detail

    Table 50. Abbott Laboratories Business Overview

    Table 51. Abbott Laboratories Circulating Biomarker for Liquid Biopsy Product

    Table 52. Abbott Laboratories Revenue in Circulating Biomarker for Liquid Biopsy Business (2018-2023) & (US$ Million)

    Table 53. Abbott Laboratories Recent Development

    Table 54. Becton, Dickinson and Company Company Detail

    Table 55. Becton, Dickinson and Company Business Overview

    Table 56. Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Product

    Table 57. Becton, Dickinson and Company Revenue in Circulating Biomarker for Liquid Biopsy Business (2018-2023) & (US$ Million)

    Table 58. Becton, Dickinson and Company Recent Development

    Table 59. GE Healthcare Company Detail

    Table 60. GE Healthcare Business Overview

    Table 61. GE Healthcare Circulating Biomarker for Liquid Biopsy Product

    Table 62. GE Healthcare Revenue in Circulating Biomarker for Liquid Biopsy Business (2018-2023) & (US$ Million)

    Table 63. GE Healthcare Recent Development

    Table 64. Epigenomics AG Company Detail

    Table 65. Epigenomics AG Business Overview

    Table 66. Epigenomics AG Circulating Biomarker for Liquid Biopsy Product

    Table 67. Epigenomics AG Revenue in Circulating Biomarker for Liquid Biopsy Business (2018-2023) & (US$ Million)

    Table 68. Epigenomics AG Recent Development

    Table 69. Agilent Technologies Company Detail

    Table 70. Agilent Technologies Business Overview

    Table 71. Agilent Technologies Circulating Biomarker for Liquid Biopsy Product

    Table 72. Agilent Technologies Revenue in Circulating Biomarker for Liquid Biopsy Business (2018-2023) & (US$ Million)

    Table 73. Agilent Technologies Recent Development

    Table 74. Biocept Company Detail

    Table 75. Biocept Business Overview

    Table 76. Biocept Circulating Biomarker for Liquid Biopsy Product

    Table 77. Biocept Revenue in Circulating Biomarker for Liquid Biopsy Business (2018-2023) & (US$ Million)

    Table 78. Biocept Recent Development

    Table 79. Affymetrix Company Detail

    Table 80. Affymetrix Business Overview

    Table 81. Affymetrix Circulating Biomarker for Liquid Biopsy Product

    Table 82. Affymetrix Revenue in Circulating Biomarker for Liquid Biopsy Business (2018-2023) & (US$ Million)

    Table 83. Affymetrix Recent Development

    Table 84. Fluxion Biosciences Company Detail

    Table 85. Fluxion Biosciences Business Overview

    Table 86. Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Product

    Table 87. Fluxion Biosciences Revenue in Circulating Biomarker for Liquid Biopsy Business (2018-2023) & (US$ Million)

    Table 88. Fluxion Biosciences Recent Development

    Table 89. Research Programs/Design for This Report

    Table 90. Key Data Information from Secondary Sources

    Table 91. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Circulating Biomarker for Liquid Biopsy Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Circulating Biomarker for Liquid Biopsy Market Share by Type: 2022 VS 2029

    Figure 3. Circulating Tumor Cells (CTCs) Features

    Figure 4. Circulating Tumor DNA (ctDNA) Features

    Figure 5. Cell-Free DNA (cfDNA) Features

    Figure 6. Extracellular Vesicles (EVs) Features

    Figure 7. Others Features

    Figure 8. Global Circulating Biomarker for Liquid Biopsy Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Circulating Biomarker for Liquid Biopsy Market Share by Application: 2022 VS 2029

    Figure 10. Early Cancer Screening Case Studies

    Figure 11. Therapy Selection Case Studies

    Figure 12. Treatment Monitoring Case Studies

    Figure 13. Recurrence Monitoring Orthopedics Case Studies

    Figure 14. Circulating Biomarker for Liquid Biopsy Report Years Considered

    Figure 15. Global Circulating Biomarker for Liquid Biopsy Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 16. Global Circulating Biomarker for Liquid Biopsy Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 17. Global Circulating Biomarker for Liquid Biopsy Market Share by Region: 2022 VS 2029

    Figure 18. Global Circulating Biomarker for Liquid Biopsy Market Share by Players in 2022

    Figure 19. Global Top Circulating Biomarker for Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Biomarker for Liquid Biopsy as of 2022)

    Figure 20. The Top 10 and 5 Players Market Share by Circulating Biomarker for Liquid Biopsy Revenue in 2022

    Figure 21. North America Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. North America Circulating Biomarker for Liquid Biopsy Market Share by Country (2018-2029)

    Figure 23. United States Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Canada Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Europe Circulating Biomarker for Liquid Biopsy Market Share by Country (2018-2029)

    Figure 27. Germany Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. France Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. U.K. Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Italy Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Russia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Nordic Countries Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Share by Region (2018-2029)

    Figure 35. China Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Japan Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. South Korea Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. India Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Australia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Latin America Circulating Biomarker for Liquid Biopsy Market Share by Country (2018-2029)

    Figure 43. Mexico Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Brazil Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Share by Country (2018-2029)

    Figure 47. Turkey Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Saudi Arabia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Abbott Laboratories Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2018-2023)

    Figure 50. Becton, Dickinson and Company Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2018-2023)

    Figure 51. GE Healthcare Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2018-2023)

    Figure 52. Epigenomics AG Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2018-2023)

    Figure 53. Agilent Technologies Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2018-2023)

    Figure 54. Biocept Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2018-2023)

    Figure 55. Affymetrix Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2018-2023)

    Figure 56. Fluxion Biosciences Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2018-2023)

    Figure 57. Bottom-up and Top-down Approaches for This Report

    Figure 58. Data Triangulation

    Figure 59. Key Executives Interviewed